PET imaging of new target CDK19 in prostate cancer.
Dong DaiJiang YuTing HuangYansheng LiZiyang WangShuangmeng YangShuai LiYanli LiWenfeng GouDeguan LiWenbin HouSaijun FanYiliang LiYu ZhaoPublished in: European journal of nuclear medicine and molecular imaging (2023)
Ga-CDK19 may merit further evaluation as a predictive biomarker for PET scans in prospective cohorts and may facilitate the identification of molecular types of prostate cancer independent of PSMA.